A randomised controlled trial of 225 versus 300 IU recombinant follicle stimulating hormone (FSH) for ovarian stimulation in predicted normal responders by antral follicle count.
Phase of Trial: Phase III
Latest Information Update: 13 Oct 2015
At a glance
- Drugs Follitropin alfa (Primary)
- Indications Infertility
- Focus Therapeutic Use
- 29 Mar 2010 Primary endpoint 'Number of oocytes' has not been met.
- 29 Mar 2010 Results published in BJOG: An International Journal of Obstetrics and Gynaecology.
- 01 Dec 2008 New trial record.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History